Stereoselective 1,3-Cyclotelomerization of Butadiene with Dienophiles under Nickel Catalysis

13 February 2025, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The discovery of new chemoselectivity with readily accessible chemicals is important to expand the reaction space for modern chemistry. For dienes and dienophiles, most people will naturally use them to carry out the classic Diels-Alder reaction to construct six-membered cyclic compounds. Here, we demonstrated a chemoselective coupling of butadiene with dienophiles through a stereoselective 1,3-cyclotelomerization. By utilizing robust Ni/IPr catalysis, valuable bicyclic products were created with high regio- and chemoselectivities under mild conditions. Asymmetric cyclotelomerization enabled by chiral NHC ligand was also performed, generating enantioenriched bicyclic compounds. Mechanistic studies reveal that the reaction might start with oxidative cyclometallation between two molecules of 1,3-diene and Ni(0) species, which then undergoes [3+2]-cycloaddition via an electron transfer process. The products can undergo a variety of intricate transformations, which emphasizes the potential applications of this strategy. It is hoped that the discovery of this protocol will further inspire people to rethink the classic organic reactions.

Keywords

telomerization
butadiene
nickel catalysis
5-5 fused bicycle
enantioselectivity

Supplementary materials

Title
Description
Actions
Title
Supplementary Information
Description
Supporting Information For Stereoselective 1,3-Cyclotelomerization of Butadiene with Dienophiles under Nickel Catalysis
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.